Literature DB >> 27228110

Association Between Occlusion Therapy and Optotype Visual Acuity in Children Using Data From the Infant Aphakia Treatment Study: A Secondary Analysis of a Randomized Clinical Trial.

Carolyn Drews-Botsch1, Marianne Celano2, George Cotsonis3, E Eugenie Hartmann4, Scott R Lambert5.   

Abstract

IMPORTANCE: Patching has been a mainstay in treating unilateral congenital cataract. However, its efficacy has not been rigorously assessed.
OBJECTIVE: To examine the association between patching and visual acuity in a cohort of children treated for unilateral congenital cataract. DESIGN, SETTING, AND PARTICIPANTS: This study was a secondary analysis of a randomized clinical trial (Infant Aphakia Treatment Study) of infants born from August 1, 2004, through December 31, 2008, who were treated with 1 of 2 treatments for unilateral congenital cataract and followed up to 5 years of age. Data analysis was performed from March 1, 2013, to March 1, 2016.
INTERVENTIONS: Cataract extraction and randomization to receipt of an intraocular lens vs being left aphakic for the first 5 years of life. MAIN OUTCOMES AND MEASURES: Caregivers reported patching in the previous 48 hours in quarterly semistructured telephone interviews. The mean number of hours of patching per day was calculated from surgery to the first birthday (n = 92) and between 12 and 48 months of age (n = 102). Monocular optotype acuity was assessed at 4½ years of age by a traveling examiner using the Aphakia Treatment Study HOTV protocol.
RESULTS: The Infant Aphakia Treatment Study enrolled 114 children; 57 were randomized to each treatment group. At 4½ years of age, optotype visual acuity was assessed in 112 children. The current analyses exclude an additional 3 children (2 who had adverse events that limited visual potential and 1 who had Stickler syndrome), leaving 109 total children analyzed (59 female [54.1%] and 92 white [84.4%]). Caregivers reported patching their children a mean (SD) of 3.73 (1.47) hours per day in the first year of life and 3.43 (2.04) hours per day thereafter. An association between reported patching and treatment was not identified (mean difference in first year, -0.29 hours per day; 95% CI, -0.90 to 0.33 hours per day; mean difference between 12 and 48 months of age, -0.40 hours per day; 95% CI, -1.20 to 0.40 hours per day). Visual acuity was associated with reported hours of patching in the first year of life (r = -0.32; 95% CI, -0.49 to -0.13) and between 12 and 48 months of age (r = -0.36; 95% CI, -0.52 to -0.18). However, patching accounted for less than 15% of the variance in logMAR acuity at 4½ years of age. CONCLUSIONS AND RELEVANCE: These results support the association of occlusion throughout the preschool years with improved visual acuity in infants treated for unilateral congenital cataract. However, similar visual outcomes were achieved with varying amounts of patching. These conclusions should be interpreted in the context of limitations related to generalizability from incomplete data collected in a clinical trial. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00212134.

Entities:  

Mesh:

Year:  2016        PMID: 27228110      PMCID: PMC4982828          DOI: 10.1001/jamaophthalmol.2016.1365

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN: 2168-6165            Impact factor:   7.389


  24 in total

1.  Computerized method of visual acuity testing: adaptation of the amblyopia treatment study visual acuity testing protocol.

Authors:  P S Moke; A H Turpin; R W Beck; J M Holmes; M X Repka; E E Birch; R W Hertle; R T Kraker; J M Miller; C A Johnson
Journal:  Am J Ophthalmol       Date:  2001-12       Impact factor: 5.258

2.  The amblyopia treatment study visual acuity testing protocol.

Authors:  J M Holmes; R W Beck; M X Repka; D A Leske; R T Kraker; R C Blair; P S Moke; E E Birch; R A Saunders; R W Hertle; G E Quinn; K A Simons; J M Miller
Journal:  Arch Ophthalmol       Date:  2001-09

3.  Form-vision deprivation amblyopia and strabismic amblyopia.

Authors:  Y Uemura; O Katsumi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1988       Impact factor: 3.117

Review 4.  Occlusion for stimulus deprivation amblyopia.

Authors:  Aileen Antonio-Santos; Satyanarayana S Vedula; Sarah R Hatt; Christine Powell
Journal:  Cochrane Database Syst Rev       Date:  2014-02-06

5.  Compliance in antiamblyopia occlusion therapy.

Authors:  P Nucci; R Alfarano; A Piantanida; R Brancato
Journal:  Acta Ophthalmol (Copenh)       Date:  1992-02

Review 6.  Advances in amblyopia: what have we learned from PEDIG trials?

Authors:  Kammi B Gunton
Journal:  Pediatrics       Date:  2013-02-04       Impact factor: 7.124

7.  Monocular acuity norms for the Teller Acuity Cards between ages one month and four years.

Authors:  D L Mayer; A S Beiser; A F Warner; E M Pratt; K N Raye; J M Lang
Journal:  Invest Ophthalmol Vis Sci       Date:  1995-03       Impact factor: 4.799

8.  Modulation of amblyopia therapy following early surgery for unilateral congenital cataracts.

Authors:  I C Lloyd; J G Dowler; A Kriss; L Speedwell; D A Thompson; I Russell-Eggitt; D Taylor
Journal:  Br J Ophthalmol       Date:  1995-09       Impact factor: 4.638

9.  The health-related quality of life of children with congenital cataract: findings of the British Congenital Cataract Study.

Authors:  Melanie Chak; Jugnoo Sangeeta Rahi
Journal:  Br J Ophthalmol       Date:  2007-01-23       Impact factor: 4.638

10.  Treatment dose-response in amblyopia therapy: the Monitored Occlusion Treatment of Amblyopia Study (MOTAS).

Authors:  Catherine E Stewart; Merrick J Moseley; David A Stephens; Alistair R Fielder
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-09       Impact factor: 4.799

View more
  8 in total

1.  Association of Contact Lens Adherence With Visual Outcome in the Infant Aphakia Treatment Study: A Secondary Analysis of a Randomized Clinical Trial.

Authors:  Caroline H Cromelin; Carolyn Drews-Botsch; Buddy Russell; Scott R Lambert
Journal:  JAMA Ophthalmol       Date:  2018-03-01       Impact factor: 7.389

2.  Spectacle Adherence Among Four-Year-Old Children in the Infant Aphakia Treatment Study.

Authors:  Scott R Lambert; Lindreth DuBois; George Cotsonis; E Eugenie Hartmann; Carolyn Drews-Botsch
Journal:  Am J Ophthalmol       Date:  2019-01-08       Impact factor: 5.258

Review 3.  Surgical interventions for bilateral congenital cataract in children aged two years and under.

Authors:  Ritvij Singh; Lucy Barker; Sean I Chen; Anupa Shah; Vernon Long; Annegret Dahlmann-Noor
Journal:  Cochrane Database Syst Rev       Date:  2022-09-15

4.  Correlation of monocular grating acuity at age 12 months with recognition acuity at age 4.5 years: findings from the Infant Aphakia Treatment Study.

Authors:  E Eugenie Hartmann; Carolyn Drews-Botsch; Lindreth G DuBois; George Cotsonis; Scott R Lambert
Journal:  J AAPOS       Date:  2018-07-20       Impact factor: 1.220

5.  Outcome of Pediatric Cataract Surgeries in a Tertiary Center in Switzerland.

Authors:  Sarah Claudia Ambroz; Marc Töteberg-Harms; James V M Hanson; Jens Funk; Daniel Barthelmes; Christina Gerth-Kahlert
Journal:  J Ophthalmol       Date:  2018-02-25       Impact factor: 1.909

6.  Parenting Stress and Adherence to Occlusion Therapy in the Infant Aphakia Treatment Study: A Secondary Analysis of a Randomized Clinical Trial.

Authors:  Carolyn Drews-Botsch; Marianne Celano; George Cotsonis; Lindreth DuBois; Scott R Lambert
Journal:  Transl Vis Sci Technol       Date:  2019-01-02       Impact factor: 3.283

7.  Effect of Timing of Initial Cataract Surgery, Compliance to Amblyopia Therapy on Outcomes of Secondary Intraocular Lens Implantation in Chinese Children: A Retrospective Case Series.

Authors:  Liuyang Li; Yan Wang; Caihong Xue
Journal:  J Ophthalmol       Date:  2018-03-22       Impact factor: 1.909

Review 8.  Cataract management in children: a review of the literature and current practice across five large UK centres.

Authors:  J E Self; R Taylor; A L Solebo; S Biswas; M Parulekar; A Dev Borman; J Ashworth; R McClenaghan; J Abbott; E O'Flynn; D Hildebrand; I C Lloyd
Journal:  Eye (Lond)       Date:  2020-08-10       Impact factor: 3.775

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.